The Bioproduct Research and Development (BR&D) organization delivers innovative medicines through the development and commercialization of insulins, peptides, oligonucleotides, monoclonal antibodies, antibody-drug conjugates (ADCs), novel therapeutic proteins, and gene therapy systems. BR&D is a multidisciplinary group with deep scientific expertise that collaborates closely with discovery and manufacturing partners. Located in Indianapolis, IN, our scientists have access to world-class pharmaceutical development and engineering capabilities.
In this role, you will join a collaborative team of scientists dedicated to advancing bioassay science in support of Lilly’s growing portfolio of biotherapeutics and next-generation modalities.
You will play a critical role in ensuring that the potency and biological activity of Lilly’s medicines are accurately characterized from early development through commercialization, directly supporting patient access to safe and effective therapies. This is an opportunity to work hands-on with cutting-edge technologies — including cell and gene therapy platforms, engineered cell lines, and genome editing tools — while building deep technical expertise in bioassay development, a discipline central to both product quality and regulatory success. You will partner closely with colleagues across Analytical Development, Quality Control, Manufacturing, and Regulatory Affairs, gaining broad visibility into the end-to-end product lifecycle and the chance to shape how new assay technologies are evaluated and adopted across the organization.
For scientists looking to grow their careers in bioanalytical and cell-based assay science within a fast-paced, innovation-driven environment, this role offers meaningful technical challenges alongside strong mentorship and cross-functional exposure.